Exisulind continues to prevent colonic adenoma formation in familial adenomatous polyposis (FAP) patients treated for 18 months

Autor:	Jan Björk, Carol A. Burke, Sapna Syngal, Rosalind U. van Stolk, Martin Luchtefeld, Scott K. Kuwada, Rolf Hultcrantz, Miguel Rodriquez, V. Alin Botomon, Lawrence Wruble, Madir Arber
Rok vydání:	2000
Předmět:	medicine.medical_specialty Hepatology business.industry Colonic Adenoma Gastroenterology medicine.disease Familial adenomatous polyposis chemistry.chemical_compound chemistry Exisulind Internal medicine medicine business
Zdroj:	Gastroenterology. 118:A657
ISSN:	0016-5085
DOI:	10.1016/s0016-5085(00)84767-8
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7fdc69a194586c3780e45f493cdbae27 https://doi.org/10.1016/s0016-5085(00)84767-8 Zobrazit plný text záznamu